RCBTB2
RCC1 and BTB domain-containing protein 2
Also known as: CHC1L, RCBT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95199
- Gene
- RCBTB2
- Ensembl
- ENSG00000136161
- Chromosome
- 13
- Canonical length
- 551 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a protein containing two C-terminal BTB/POZ domains that is related to regulator of chromosome condensation (RCC). The encoded protein may act as a guanine nucleotide exchange factor. This gene is observed to be lost or underexpressed in prostate cancers. There is a pseudogene of this gene on chromosome 10. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]
Canonical amino-acid sequenceUniProt
551 residues, UniProt reviewed canonical sequence.
>O95199|RCBTB2
1 MEEELPLFSG DSGKPVQATL SSLKMLDVGK WPIFSLCSEE ELQLIRQACV FGSAGNEVLY
61 TTVNDEIFVL GTNCCGCLGL GDVQSTIEPR RLDSLNGKKI ACLSYGSGPH IVLATTEGEV
121 FTWGHNAYSQ LGNGTTNHGL VPCHISTNLS NKQVIEVACG SYHSLVLTSD GEVFAWGYNN
181 SGQVGSGSTV NQPIPRRVTG CLQNKVVVTI ACGQMCCMAV VDTGEVYVWG YNGNGQLGLG
241 NSGNQPTPCR VAALQGIRVQ RVACGYAHTL VLTDEGQVYA WGANSYGQLG TGNKSNQSYP
301 TPVTVEKDRI IEIAACHSTH TSAAKTQGGH VYMWGQCRGQ SVILPHLTHF SCTDDVFACF
361 ATPAVTWRLL SVEPDDHLTV AESLKREFDN PDTADLKFLV DGKYIYAHKV LLKIRCEHFR
421 SSLEDNEDDI VEMSEFSYPV YRAFLEYLYT DSISLSPEEA VGLLDLATFY RENRLKKLCQ
481 QTIKQGICEE NAIALLSAAV KYDAQDLEEF CFRFCINHLT VVTQTSGFAE MDHDLLKNFI
541 SKASRVGAFK NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCBTB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 26 nTPM
- ovary: 23 nTPM
- salivary gland: 22 nTPM
- seminal vesicle: 19 nTPM
- placenta: 17 nTPM
- spleen: 16 nTPM
Single-cell type
- microglia: 164 nCPM
- thymocytes: 164 nCPM
- neutrophils: 101 nCPM
- monocytes: 78 nCPM
- macrophages: 76 nCPM
- choroid plexus epithelial cells: 69 nCPM
Immune cell
- neutrophil: 55 nTPM
- classical monocyte: 40 nTPM
- intermediate monocyte: 29 nTPM
- non-classical monocyte: 28 nTPM
- myeloid DC: 27 nTPM
- total PBMC: 21 nTPM
Brain region
- choroid plexus: 26 nTPM
- white matter: 19 nTPM
- hypothalamus: 17 nTPM
- spinal cord: 17 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- digestive tract development
- liver development
- lymph node development
- spleen development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCBTB2 as an antibody target. Whether an autoantibody or antibody against RCBTB2 could matter depends on whether native RCBTB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCBTB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCBTB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...